Aaron Hardin

494 total citations
16 papers, 292 citations indexed

About

Aaron Hardin is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Aaron Hardin has authored 16 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Aaron Hardin's work include Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (3 papers) and RNA and protein synthesis mechanisms (3 papers). Aaron Hardin is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (3 papers) and RNA and protein synthesis mechanisms (3 papers). Aaron Hardin collaborates with scholars based in United States, Thailand and United Kingdom. Aaron Hardin's co-authors include Nadav Ahituv, Walter L. Eckalbar, Christian Vaisse, Serena Tamura, Navneet Matharu, Sawitree Rattanasopha, Adélaïde Bernard, Yi Wang, Lenka Maliskova and Lesli A. Kiedrowski and has published in prestigious journals such as Nature, Science and Journal of Clinical Oncology.

In The Last Decade

Aaron Hardin

15 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Hardin United States 6 220 74 35 26 26 16 292
Joe Harman United Kingdom 8 245 1.1× 32 0.4× 16 0.5× 12 0.5× 19 0.7× 12 321
Luke C. Bartelt United States 7 200 0.9× 51 0.7× 36 1.0× 16 0.6× 34 1.3× 10 260
Qiaoyan Yang China 10 407 1.9× 50 0.7× 75 2.1× 15 0.6× 45 1.7× 15 480
Sawitree Rattanasopha Thailand 4 227 1.0× 112 1.5× 13 0.4× 9 0.3× 18 0.7× 5 297
Xia Hou United States 10 195 0.9× 29 0.4× 22 0.6× 78 3.0× 42 1.6× 17 301
Jonathan D. Lee United States 7 359 1.6× 48 0.6× 29 0.8× 27 1.0× 175 6.7× 14 459
Tristin Liu United States 4 488 2.2× 113 1.5× 12 0.3× 8 0.3× 49 1.9× 4 540
Christine Gran Neurauter Norway 9 280 1.3× 51 0.7× 29 0.8× 23 0.9× 40 1.5× 11 320
Danielle Bittencourt United States 11 393 1.8× 97 1.3× 58 1.7× 32 1.2× 45 1.7× 11 479
Amal Hashem Saudi Arabia 9 236 1.1× 138 1.9× 32 0.9× 11 0.4× 21 0.8× 11 354

Countries citing papers authored by Aaron Hardin

Since Specialization
Citations

This map shows the geographic impact of Aaron Hardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Hardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Hardin more than expected).

Fields of papers citing papers by Aaron Hardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Hardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Hardin. The network helps show where Aaron Hardin may publish in the future.

Co-authorship network of co-authors of Aaron Hardin

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Hardin. A scholar is included among the top collaborators of Aaron Hardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Hardin. Aaron Hardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Sinicrope, Frank A., et al.. (2025). Tissue-free circulating tumor DNA assay and patient outcome in a phase III trial of FOLFOX-based adjuvant chemotherapy (Alliance N0147).. Journal of Clinical Oncology. 43(16_suppl). 3504–3504. 1 indexed citations
3.
Das, Amar K., et al.. (2024). AI-generated synthetic clinical-genomic data for precision oncology research: Validation using a case study on lung adenocarcinoma.. Journal of Clinical Oncology. 42(16_suppl). e13627–e13627. 1 indexed citations
4.
Kasi, Pashtoon Murtaza, Jiemin Liao, Jason S. Starr, et al.. (2023). Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes. JCO Precision Oncology. 7(7). e2300118–e2300118. 8 indexed citations
5.
Kobayashi, Yoshihisa, Jiaqi Li, Kristin S. Price, et al.. (2022). Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers. Nature. 603(7900). 335–342. 31 indexed citations
6.
Kasi, Pashtoon Murtaza, Samuel J. Klempner, Jason S. Starr, et al.. (2022). Clinical utility of microsatellite instability (MSI-H) identified on liquid biopsy in advanced gastrointestinal cancers (aGI).. Journal of Clinical Oncology. 40(4_suppl). 56–56. 8 indexed citations
7.
Hanna, David B., Junhua Yu, Aaron Hardin, et al.. (2021). Abstract PS18-15: Real-world clinical-genomic data identifies the ESR1 clonal and subclonal circulating tumor DNA (ctDNA) landscape and provides insight into clinical outcomes. Cancer Research. 81(4_Supplement). PS18–15. 2 indexed citations
8.
Grivas, Petros, Lesli A. Kiedrowski, Guru Sonpavde, et al.. (2021). Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial Carcinoma. Bladder Cancer. 7(2). 143–148. 3 indexed citations
9.
Richardson, Aaron O., Aaron Hardin, Jing Zhao, et al.. (2021). Abstract 572: The liquid biopsy Guardant360 CDx has robust performance at low inputs allowing for high rate of returning patient results. Cancer Research. 81(13_Supplement). 572–572. 2 indexed citations
10.
Yu, Junhua, Christopher Ton, David B. Hanna, et al.. (2021). Abstract PS18-28: Genomic heterogeneity and associated clinical outcomes of breast cancers treated with CDK4/6 inhibitors: Insights from real-world clinical genomic data. Cancer Research. 81(4_Supplement). PS18–28. 2 indexed citations
11.
Hardin, Aaron, et al.. (2020). Abstract 4421: Development of a clinical-genomic database to study tumor evolution and molecular biomarkers of drug resistance in a real-world setting. Cancer Research. 80(16_Supplement). 4421–4421. 1 indexed citations
12.
Kiedrowski, Lesli A., Dejan Juric, Aaron Hardin, et al.. (2020). Abstract P4-10-15: PIK3CA mutational analysis using cell-free DNA next-generation sequencing detects activating mutations that may be missed with targeted hot-spot testing. Cancer Research. 80(4_Supplement). P4–10. 1 indexed citations
13.
Hardin, Aaron, Kimberly A. Nevonen, Walter L. Eckalbar, Lucia Carbone, & Nadav Ahituv. (2019). Comparative Genomic Characterization of the Multimammate Mouse Mastomys coucha. Molecular Biology and Evolution. 36(12). 2805–2812. 6 indexed citations
14.
Matharu, Navneet, Sawitree Rattanasopha, Serena Tamura, et al.. (2019). CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Yearbook of pediatric endocrinology. 8 indexed citations
15.
Matharu, Navneet, Sawitree Rattanasopha, Serena Tamura, et al.. (2018). CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Science. 363(6424). 216 indexed citations
16.
Hardin, Aaron, et al.. (2006). A molecular characterization of spontaneous frameshift mutagenesis within the trpA gene of Escherichia coli. DNA repair. 6(2). 177–189. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joe Harman Breakdown of academic impact, for papers by Luke C. Bartelt Breakdown of academic impact, for papers by Qiaoyan Yang Breakdown of academic impact, for papers by Sawitree Rattanasopha Breakdown of academic impact, for papers by Xia Hou Breakdown of academic impact, for papers by Jonathan D. Lee Breakdown of academic impact, for papers by Tristin Liu Breakdown of academic impact, for papers by Christine Gran Neurauter Breakdown of academic impact, for papers by Danielle Bittencourt Breakdown of academic impact, for papers by Amal Hashem
Rankless by CCL
2026